Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Switching antipsychotic medications

P J Weiden1, R Aquila, L Dalheim

  • 1Department of Psychiatry, St. Luke's-Roosevelt Hospital Center, New York, NY 10025, USA.

The Journal of Clinical Psychiatry
|January 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antipsychotic pharmacogenomics in first episode psychosis: a role for glutamate genes.

Translational psychiatry·2016
Same author

Which side effects really matter? Screening for common and distressing side effects of antipsychotic medications.

Journal of psychiatric practice·2005
Same author

Ziprasidone: a new atypical antipsychotic.

Journal of psychiatric practice·2005
Same author

Ziprasidone update.

Journal of psychiatric practice·2005
Same author

Trauma and disaster in psychiatrically vulnerable populations.

Journal of psychiatric practice·2005
Same author

Medication supervision and adherence of persons with psychotic disorders in residential treatment settings: a pilot study.

The Journal of clinical psychiatry·2001
Same journal

Major Depressive Disorder and PTSD Treatment Outcome in Interpersonal Psychotherapy and Prolonged Exposure.

The Journal of clinical psychiatry·2026
Same journal

Psychiatrists and Medical Aid in Dying: Entering Uncharted Waters.

The Journal of clinical psychiatry·2026
Same journal

Mind and Metabolism in Crisis: US Mortality Involving Obesity and Psychiatric Disorders-Trends, Disparities, and ARIMA Projections.

The Journal of clinical psychiatry·2026
Same journal

Generative AI for the Clinical Psychopharmacologist: Is It Ready for Prime Time?

The Journal of clinical psychiatry·2026
Same journal

Posttrauma Benzodiazepine Use and Subsequent PTSD: A Population-Wide Analysis Following Extreme Traumatic Exposure.

The Journal of clinical psychiatry·2026
Same journal

The Challenges of PTSD Prevention: Placing Benzodiazepine Use in Context.

The Journal of clinical psychiatry·2026
See all related articles

Switching to atypical antipsychotics may improve schizophrenia symptom control and side effect profiles. This paper reviews factors to consider, including contraindications and switching techniques, focusing on olanzapine.

Area of Science:

  • Psychiatry
  • Pharmacology

Background:

  • Conventional antipsychotics are standard treatments for schizophrenia.
  • Atypical antipsychotics offer potential advantages in side effect profiles and symptom control.

Observation:

  • Most patients on conventional antipsychotics could potentially benefit from switching to atypical agents.
  • Key considerations for switching include countervailing factors, indications, and contraindications.

Findings:

  • This paper reviews the rationale, benefits, and risks associated with switching antipsychotic medications.
  • It details factors influencing the decision to switch and discusses various switching techniques.
  • Special attention is given to the atypical antipsychotic olanzapine.

Implications:

Related Experiment Videos

  • Informed decisions regarding antipsychotic medication switching can optimize schizophrenia treatment outcomes.
  • Understanding switching techniques and considerations is crucial for clinicians managing schizophrenia.
  • The review provides guidance for considering olanzapine as a potential alternative treatment.